Morningstar Investment Services’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,245
| Closed | -$285K | – | 407 |
|
|
2024
Q2 | $285K | Sell |
1,245
-182
| -13% | -$41.7K | ﹤0.01% | 319 |
|
|
2024
Q1 | $309K | Sell |
1,427
-429
| -23% | -$92.9K | ﹤0.01% | 284 |
|
|
2023
Q4 | $484K | Buy |
1,856
+1,023
| +123% | +$267K | ﹤0.01% | 291 |
|
|
2023
Q3 | $215K | Sell |
833
-42
| -5% | -$10.8K | ﹤0.01% | 271 |
|
|
2023
Q2 | $247K | Buy |
+875
| New | +$247K | ﹤0.01% | 235 |
|
|
2022
Q3 | – | Sell |
-13,537
| Closed | -$2.78M | – | 220 |
|
|
2022
Q2 | $2.78M | Sell |
13,537
-629
| -4% | -$129K | 0.04% | 139 |
|
|
2022
Q1 | $2.99M | Hold |
14,166
| – | – | 0.03% | 155 |
|
|
2021
Q4 | $3.4M | Buy |
14,166
+3,125
| +28% | +$750K | 0.04% | 148 |
|
|
2021
Q3 | $3.15M | Buy |
11,041
+1,810
| +20% | +$517K | 0.04% | 149 |
|
|
2021
Q2 | $3.19M | Sell |
9,231
-15,729
| -63% | -$5.44M | 0.04% | 149 |
|
|
2021
Q1 | $6.89M | Hold |
24,960
| – | – | 0.09% | 133 |
|
|
2020
Q4 | $6.11M | Sell |
24,960
-438
| -2% | -$107K | 0.09% | 133 |
|
|
2020
Q3 | $7.17M | Hold |
25,398
| – | – | 0.11% | 125 |
|
|
2020
Q2 | $6.61M | Buy |
+25,398
| New | +$6.61M | 0.11% | 126 |
|
|
2019
Q3 | – | Sell |
-28,597
| Closed | -$6.69M | – | 195 |
|
|
2019
Q2 | $6.69M | Sell |
28,597
-4,744
| -14% | -$1.11M | 0.11% | 130 |
|
|
2019
Q1 | $7.88M | Buy |
+33,341
| New | +$7.88M | 0.14% | 115 |
|
|
2017
Q1 | – | Sell |
-1,077
| Closed | -$305K | – | 186 |
|
|
2016
Q4 | $305K | Sell |
1,077
-4,562
| -81% | -$1.29M | 0.01% | 162 |
|
|
2016
Q3 | $1.77M | Sell |
5,639
-353
| -6% | -$110K | 0.05% | 147 |
|
|
2016
Q2 | $1.47M | Sell |
5,992
-3,839
| -39% | -$941K | 0.05% | 149 |
|
|
2016
Q1 | $2.56M | Sell |
9,831
-400
| -4% | -$104K | 0.09% | 140 |
|
|
2015
Q4 | $3.13M | Buy |
+10,231
| New | +$3.13M | 0.12% | 124 |
|